| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
arylacetamide deacetylase | 0.631 | 0.615 | 2.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
adeno-associated virus integration site 1 | 0.595 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
ATP binding cassette subfamily B member 11 | 0.566 | 0.654 | 1.6E-12 |
|
disease | 0.090 | None | 0.889 | 9 | 1 | 2004 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 4 | 0.529 | 0.615 | 2.2E-07 |
|
disease | 0.360 | None | 0.875 | 6 | 0 | 1996 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 5 | 0.623 | 0.538 | 1.5E-37 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily D member 1 | 0.563 | 0.731 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 2003 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1985 | 2020 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
acylphosphatase 2 | 0.659 | 0.577 | 6.5E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 3 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2004 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.050 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
adenosine deaminase RNA specific | 0.501 | 0.808 | 2.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
adenosine deaminase RNA specific B1 | 0.588 | 0.654 | 0.80 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
adhesion G protein-coupled receptor F1 | 0.736 | 0.308 | 2.0E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1991 | 2014 | ||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1991 | 2012 | |||||||||
|
alcohol dehydrogenase 5 (class III), chi polypeptide | 0.604 | 0.731 | 2.5E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2018 | ||||||||
|
adiponectin receptor 1 | 0.529 | 0.808 | 0.66 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 |